Showing results (1-10 of 644) with videos related to
Sort By:
Pageof 65
Clinical Genitourinary Cancer|September 2, 2019
Importance of Multiparametric Evaluation of Immune-Related T-Cell Markers in Renal-Cell CarcinomaAtsunari Kawashima, Motohide Uemura, Norio NonomuraAnticancer Research|December 30, 2022
Diagnosing and Prognosing Bone Metastasis in Prostate Cancer: Clinical Utility of Blood BiomarkersGaku Yamamichi, Taigo Kato, Motohide Uemura, et al.Hinyokika Kiyo. Acta Urologica Japonica|January 19, 2013
[Treatment strategy for stage I testicular germ cell tumor]Yasutomo Nakai, Akira Nagahara, Motohide Uemura, et al.Clinical Nuclear Medicine|November 19, 2020
Duodenal Adenocarcinoma Mimicking Metastasis of Prostate Cancer on 18F-Prostate-Specific Membrane Antigen-1007 PET/CTFumihiko Soeda, Tadashi Watabe, Hiroki Kato, et al.Journal of Clinical Medicine|February 10, 2019
Obesity, Inflammation, and Prostate CancerKazutoshi Fujita, Takuji Hayashi, Makoto Matsushita, et al.Hinyokika Kiyo. Acta Urologica Japonica|October 27, 2015
[Urethral Fistula and Scrotal Abscess Associated with Colovesical Fistula Due to the Sigmoid Colon Cancer]Shigeaki Nakazawa, Motohide Uemura, Yasushi Miyagawa, et al.Anticancer Research|February 29, 2024
Current Status of Prostate-specific Membrane Antigen-targeted Alpha Radioligand Therapy in Prostate CancerGaku Yamamichi, Taigo Kato, Tadashi Watabe, et al.Endocrine-Related Cancer|October 20, 2017
A novel model to predict positive prostate biopsy based on serum androgen levelTakeshi Ujike, Motohide Uemura, Atsunari Kawashima, et al.International Journal of Clinical Oncology|March 5, 2013
Weekly, low-dose docetaxel combined with estramustine for Japanese castration-resistant prostate cancer: its efficacy and safety profile compared with tri-weekly standard-dose treatmentYasutomo Nakai, Kazuo Nishimura, Masashi Nakayama, et al.Pageof 65